Maze Therapeutics

mazetx.com

Maze Therapeutics is a clinical-stage biotechnology company dedicated to developing small molecule precision medicines for common diseases, particularly focusing on kidney disease. The company leverages recent advances in genetics to create therapies that mimic protective genetic variants, addressing significant unmet medical needs. With three clinical programs expected to launch in the second half of 2024 and several others in drug discovery, Maze Therapeutics is positioned to make a substantial impact in the field of precision medicine. Their innovative approach, exemplified by the Maze Compass™ Platform, allows for targeted treatment development based on genetic insights, setting them apart in the competitive biotech landscape.